Pacific Biosciences Of California (PACB) Other Non-Current Liabilities (2010 - 2026)

Pacific Biosciences Of California has reported Other Non-Current Liabilities for 15 years, with the latest figure at $8.2 million in Q2 2026.

• On a quarterly basis, Other Non-Current Liabilities changed N/A year-over-year to $8.2 million in Q2 2026; TTM through Jun 2026 was $8.2 million, a N/A change from a year earlier, with the FY2024 full-year figure at $18.7 million, down 4.35% from the prior year.
• Other Non-Current Liabilities was $8.2 million for Q2 2026 at Pacific Biosciences Of California, up from $8.0 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $186.3 million in Q2 2023, with the low at $1.3 million in Q4 2022.
• Average Other Non-Current Liabilities over 4 years is $71.7 million, with a median of $19.5 million recorded in 2023.
• The largest YoY upside for Other Non-Current Liabilities was 22327.39% in 2022 against a maximum downside of 99.23% in 2022.
• Over 4 years, Other Non-Current Liabilities stood at $1.3 million in 2022, then soared by 1403.85% to $19.6 million in 2023, then decreased by 4.35% to $18.7 million in 2024, then sank by 56.15% to $8.2 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $8.2 million (Q2 2026), $8.0 million (Q1 2026), and $18.7 million (Q4 2024), per Business Quant data.